Monopar Therapeutics (MNPR)
(Delayed Data from NSDQ)
$0.55 USD
-0.03 (-5.21%)
Updated Aug 8, 2024 03:58 PM ET
After-Market: $0.55 0.00 (0.00%) 6:24 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.09 | 0.00% |
Earnings Summary
For their last quarter, Monopar Therapeutics (MNPR) reported earnings of -$0.10 per share, beating the Zacks Consensus Estimate of $-0.17 per share. This reflects a positive earnings surprise of 41.18%. Look out for MNPR's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year increase of 43.75%.
Earnings History
Price & Consensus
Zacks News for MNPR
Monopar Therapeutics (MNPR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
MNPR: What are Zacks experts saying now?
Zacks Private Portfolio Services